It is well-known that PSA is a prostate-specific protein, and aberrant glycosylation of PSA including Fuc-PSA and PSA-Gi was thus found to be a more specific glycobiomarker of PCa than Fuc-Hpt. This evidence concerns the gene GNAI1 and posterior cortical atrophy.